Related Experiment Video
Updated: May 7, 2026
09:35
A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform
Published on: July 16, 2016
A smad signaling network regulates islet cell proliferation
Yousef El-Gohary1, Sidhartha Tulachan, John Wiersch
1Division of Pediatric Surgery, Department of Surgery, Children's Hospital of Pittsburgh, Pittsburgh, PA.
Diabetes
|October 4, 2013
Summary
Transforming growth factor-β (TGF-β) signaling regulates pancreatic beta-cell proliferation. Smad7 is crucial for beta-cell replication after loss, involving a transient dedifferentiation process.
Area of Science:
- Endocrinology
- Cell Biology
- Diabetes Research
Background:
- Pancreatic beta-cell loss and dysfunction are central to diabetes pathogenesis.
- Beta-cell proliferation is a key defense against diabetes progression, with recent evidence highlighting beta-cell dedifferentiation as a factor in beta-cell failure.
Purpose of the Study:
- To investigate the role of transforming growth factor-beta (TGF-β) signaling in regulating beta-cell proliferation and survival.
- To elucidate the specific intracellular TGF-β regulators involved in controlling beta-cell replication after beta-cell loss.
Main Methods:
- Analysis of intracellular TGF-β regulators, including smads 7, 2, and 3, in pancreatic beta-cells.
- Investigation of the necessity of smad7 for beta-cell proliferation following beta-cell loss.
- Examination of the potential role of beta-cell dedifferentiation in smad7-mediated proliferation.
Main Results:
- A network of intracellular TGF-β regulators (smads 7, 2, and 3) was identified as controlling beta-cell proliferation.
- Smad7 was found to be essential for beta-cell proliferation after beta-cell loss.
- Smad7-mediated proliferation involves a transient, nonpathologic dedifferentiation to a pancreatic polypeptide-positive state.
- TGF-β receptor II plays a role in regulating the smad network in beta-cells.
Conclusions:
- Smad7 is a critical regulator of beta-cell replication, essential for restoring beta-cell mass after injury.
- The findings reveal a novel mechanism linking TGF-β signaling, beta-cell dedifferentiation, and proliferation, offering insights into beta-cell regeneration.
- Understanding these pathways can inform strategies for managing diabetes by promoting beta-cell recovery.
Related Concept Videos
01:16TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
01:28Insulin: The Receptor and Signaling Pathways
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
01:27Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Insulin and C-peptide are co-secreted in...
01:19Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...